State of Wisconsin Investment Board
BCLI

State of Wisconsin Investment Board’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

State of Wisconsin Investment Board’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,867
Closed -$728K – 1988
2020
Q3 		$728K Buy
+2,867
New +$587K ﹤0.01% 1372

Other funds holding BCLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State of Wisconsin Investment Board's BCLI Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2020, closing a stake of 2,867 shares — an estimated $728K sold.

State of Wisconsin Investment Board first reported a position in BCLI in Q3 2020 and held it in 1 quarter. The position peaked at $728K in Q3 2020. 90 funds tracked by Wall St. Rank hold BCLI as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 2,867 BRAINSTORM CELL THERAPUTC shares in Q4 2020, an estimated $728K.
  • State of Wisconsin Investment Board first reported a position in BRAINSTORM CELL THERAPUTC in Q3 2020 and held it in 1 quarter.
  • State of Wisconsin Investment Board's BRAINSTORM CELL THERAPUTC position peaked at $728K in Q3 2020.
  • 90 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.